Loading...
Home 2017-11-16T15:35:26+00:00

BIOMIMETIC GLUCOSE BINDING MOLECULES

Our mission is to help people with diabetes to live more normal and longer lives. We are using our proprietary Biomimetic Glucose Binding Molecules (GBM) to help enable our partners to make the next generation of Continuous Glucose Monitors (CGM) and Glucose Responsive Insulins (GRI).

SELECTIVE MONITORING

Our GBMs offer unparalleled selectivity towards glucose and function in even the most complex biological mixtures.

STABLE & VERSATILE

Our GBMs are extremely robust with a multi-year operational potential.

SCALABLE PLATFORM

Ziylo’s GBMs are produced by a streamlined, scalable synthesis and are readily derivatised for bioconjugation and chemical synthesis.

ABOUT ZIYLO

Ziylo is a supramolecular chemistry company that has developed a third ‘biomimetic’ class of glucose binding molecule (GBM). These molecules are at the core of medical devices such as Continuous Glucose Monitors (CGM) and therapeutics such as Glucose Responsive Insulins (GRI). Our platform technology is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis’ group at the University of Bristol. Inspired by nature’s carbohydrate-binding molecules (lectins), Professor Davis has become a leader in the field of ‘Synthetic Lectins’ – biomimetic molecules that are capable of binding carbohydrates like glucose in water. This award-winning chemistry has been published in Science and Nature Chemistry and has laid the foundation for the discovery our Biomimetic GBM platform.

Wakey wakey, rise and shine. ⛅️
It’s here! It is #WorldDiabetesDay! Join us today as we make noise 🗣️ to raise awareness of type 1 #diabetes.
#WDD #WDD2017

Wakey wakey, rise and shine. ⛅️
It’s here! It is #WorldDiabetesDay! Join us today as we make noise 🗣️ to raise awareness of type 1 #diabetes.
#WDD #WDD2017

We are hosting a targeted therapy showcase with @BrisSynBio on Dec 7. There are a few places still available: https://t.co/BLfIqqg1tl

We are hosting a targeted therapy showcase with @BrisSynBio on Dec 7. There are a few places still available:  https://t.co/BLfIqqg1tl

Congratulations to our CSO Dr Andy Chapman on his appointment to the @ziylo board as director. Read more here: https://t.co/6qVzadoIZY

Congratulations to our CSO Dr Andy Chapman on his appointment to the @ziylo board as director. Read more here: https://t.co/6qVzadoIZY
Load More...